Cost effectiveness of contraceptives in the United States

被引:240
作者
Trussell, James [1 ,2 ]
Lalla, Anjana M. [3 ]
Doan, Quan V. [3 ]
Reyes, Eileen [3 ]
Pinto, Lionel [3 ]
Gricar, Joseph [4 ]
机构
[1] Princeton Univ, Off Populat Res, Princeton, NJ 08540 USA
[2] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England
[3] Cerner LifeSci, Beverly Hills, CA 90212 USA
[4] Independent Healthcare Consultant, New York, NY 10002 USA
关键词
Contraception; Contraceptive devices; Cost effectiveness; Economic modeling; LEVONORGESTREL INTRAUTERINE SYSTEM; URINARY-TRACT INFECTION; UNINTENDED PREGNANCY; TUBAL-STERILIZATION; ORAL-CONTRACEPTIVES; ECTOPIC PREGNANCY; ECONOMIC-ANALYSIS; NATIONAL-SURVEY; FAMILY GROWTH; CYCLE CONTROL;
D O I
10.1016/j.contraception.2008.08.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The study was conducted to estimate the relative c perspective cost effectiveness of contraceptives in the United States from a payer's perspective. Methods: A Markov model was constructed to simulate costs for 16 contraceptive methods and no method over a 5-year period. Failure rates, adverse event rates and resource utilization were derived from the literature. Sensitivity analyses were performed on costs and failure rates. Results: Any contraceptive method is superior to "no method". The three least expensive methods were the copper-T intrauterine device (IUD) (USS647). vasectomy (USS713) and levonorgesurel (LNG)-20 intrauterine system (IUS) (USS930). Results were sensitive to the cost of contraceptive methods, the cost of an unintended pregnancy and plan disenrollment rates. Conclusion: The copper-T IUD, vasectomy and the LNG-20 IUS are the most cost-effective contraceptive methods available in the United States. Differences in method costs, the cost of in unintended pregnancy and time horizon are influential factors that determine the overall value of a contraceptive method. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 44 条
[1]  
*AB SURV US, 2003, MMWR MORB MORTAL WKL, V55
[2]  
American Medical Association, 2007, CURR PROC TERM CPT
[3]   Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive - A randomized controlled trial [J].
Audet, MC ;
Moreau, M ;
Koltun, WD ;
Waldbaum, AS ;
Shangold, G ;
Fisher, AC ;
Creasy, GW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2347-2354
[4]   Pregnancy during the use of levonorgestrel intrauterine system [J].
Backman, T ;
Rauramo, I ;
Huhtala, S ;
Koskenvuo, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) :50-54
[5]   Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users [J].
Backman, T ;
Huhtala, S ;
Blom, T ;
Luoto, R ;
Rauramo, I ;
Koskenvuo, M .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (03) :335-339
[6]   Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena®):: a 3-year follow-up study [J].
Baldaszti, E ;
Wimmer-Puchinger, B ;
Löschke, K .
CONTRACEPTION, 2003, 67 (02) :87-91
[7]   Bleeding patterns of women using extended regimens of the contraceptive vaginal ring [J].
Barreiros, Fernando Augusto ;
Guazzelli, Cnistina Aparecida Falbo ;
de Araujo, Fabio Fernando ;
Barbosa, Ricardo .
CONTRACEPTION, 2007, 75 (03) :204-208
[8]  
Chandra Anjani, 2005, Vital Health Stat 23, P1
[9]   Economic analysis of contraceptives for women [J].
Chiou, CF ;
Trussell, J ;
Reyes, E ;
Knight, K ;
Wallace, J ;
Udani, J ;
Oda, K ;
Borenstein, J .
CONTRACEPTION, 2003, 68 (01) :3-10
[10]   RETRACTED: The pharmacodynamics and efficacy of Implanon® - An overview of the data (Retracted Article) [J].
Croxatto, HB ;
Mäkäräinen, L .
CONTRACEPTION, 1998, 58 (06) :91S-97S